Parsaclisib in Patients With Relapsed or Refractory Follicular Lymphoma

Clinical trial NCT05867030 · WITHDRAWN

Trial details

NCT number: NCT05867030
Sponsor: Innovent Biologics (Suzhou) Co. Ltd.
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Follicular Lymphoma

Start date: 2023-07-28
Primary completion: 2029-08-31
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.